Polymer formulations of CETP inhibitors
US8030359B2 · kind B2 · utility
7Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2007 |
| Grant date | Oct 4, 2011 |
| Priority date | — |
| Expiry date | Mar 20, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition comprises (a) a CETP inhibiting compound, or a pharmaceutically acceptable salt thereof; (b) a concentration-enhancing polymer, and (c) optionally one or more surfactants; wherein the compound has the structure shown as Formula I below. The composition raises HDL-cholesterol and lowers LDL-cholesterol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.